Shenzhen Lifotronic Technology Balance Sheet Health
Financial Health criteria checks 5/6
Shenzhen Lifotronic Technology has a total shareholder equity of CN¥1.9B and total debt of CN¥627.0M, which brings its debt-to-equity ratio to 32.2%. Its total assets and total liabilities are CN¥2.8B and CN¥873.8M respectively. Shenzhen Lifotronic Technology's EBIT is CN¥372.7M making its interest coverage ratio -10. It has cash and short-term investments of CN¥1.7B.
Key information
32.2%
Debt to equity ratio
CN¥627.00m
Debt
| Interest coverage ratio | -10x |
| Cash | CN¥1.73b |
| Equity | CN¥1.95b |
| Total liabilities | CN¥873.76m |
| Total assets | CN¥2.82b |
Recent financial health updates
Recent updates
Is Shenzhen Lifotronic Technology (SHSE:688389) A Risky Investment?
Oct 24
Investors Still Aren't Entirely Convinced By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Earnings Despite 33% Price Jump
Oct 02Shenzhen Lifotronic Technology (SHSE:688389) Is Experiencing Growth In Returns On Capital
Aug 16Is Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Trading At A 47% Discount?
Jul 25Why Investors Shouldn't Be Surprised By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Low P/E
May 24Shenzhen Lifotronic Technology (SHSE:688389) Might Have The Makings Of A Multi-Bagger
Apr 17Financial Position Analysis
Short Term Liabilities: 688389's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥870.2M).
Long Term Liabilities: 688389's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥3.5M).
Debt to Equity History and Analysis
Debt Level: 688389 has more cash than its total debt.
Reducing Debt: 688389's debt to equity ratio has increased from 0% to 32.2% over the past 5 years.
Debt Coverage: 688389's debt is well covered by operating cash flow (56.9%).
Interest Coverage: 688389 earns more interest than it pays, so coverage of interest payments is not a concern.